Saturday, November 21, 2009

Prostate Home>
News>
Anemia drug may raise stroke risk in kidney, diabetes patients

Font size
- A
- A
- A
Email This

Bookmark

Save

Anemia drug may raise stroke risk in kidney, diabetes patients

(HealthScout) UPDATED 2009-11-03

The anemia drug Aranesp appears to double the risk of stroke in patients with kidney disease and diabetes, a study suggests. The study on 4,000 people, published in the New England Journal of Medicine, found that the risks involved for those taking Aranesp were more striking than researchers had previously thought while the benefits of the drug were less helpful than had previously been reported. Read full story >

See all Prostate News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on ProstateCommons.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.